PMC:7105881 / 31380-31701 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1017","span":{"begin":190,"end":198},"obj":"Species"},{"id":"1038","span":{"begin":273,"end":281},"obj":"Species"}],"attributes":[{"id":"A1017","pred":"tao:has_database_id","subj":"1017","obj":"Tax:694009"},{"id":"A1038","pred":"tao:has_database_id","subj":"1038","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose.\n\nSARS-CoV Subunit Vaccines Based on Full-Length S Protein\nSubunit vaccines based on SARS-CoV S protein, including full-length or tri"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T167","span":{"begin":157,"end":163},"obj":"Body_part"},{"id":"T168","span":{"begin":239,"end":246},"obj":"Body_part"},{"id":"T169","span":{"begin":284,"end":291},"obj":"Body_part"}],"attributes":[{"id":"A167","pred":"fma_id","subj":"T167","obj":"http://purl.org/sig/ont/fma/fma9637"},{"id":"A168","pred":"fma_id","subj":"T168","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A169","pred":"fma_id","subj":"T169","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose.\n\nSARS-CoV Subunit Vaccines Based on Full-Length S Protein\nSubunit vaccines based on SARS-CoV S protein, including full-length or tri"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T12","span":{"begin":157,"end":163},"obj":"Body_part"}],"attributes":[{"id":"A12","pred":"uberon_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose.\n\nSARS-CoV Subunit Vaccines Based on Full-Length S Protein\nSubunit vaccines based on SARS-CoV S protein, including full-length or tri"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T156","span":{"begin":0,"end":3},"obj":"Disease"},{"id":"T158","span":{"begin":172,"end":182},"obj":"Disease"},{"id":"T159","span":{"begin":190,"end":198},"obj":"Disease"},{"id":"T160","span":{"begin":273,"end":281},"obj":"Disease"}],"attributes":[{"id":"A156","pred":"mondo_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/MONDO_0008449"},{"id":"A157","pred":"mondo_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/MONDO_0018075"},{"id":"A158","pred":"mondo_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A159","pred":"mondo_id","subj":"T159","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A160","pred":"mondo_id","subj":"T160","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose.\n\nSARS-CoV Subunit Vaccines Based on Full-Length S Protein\nSubunit vaccines based on SARS-CoV S protein, including full-length or tri"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T415","span":{"begin":94,"end":97},"obj":"http://purl.obolibrary.org/obo/CLO_0051568"}],"text":"NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose.\n\nSARS-CoV Subunit Vaccines Based on Full-Length S Protein\nSubunit vaccines based on SARS-CoV S protein, including full-length or tri"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T182","span":{"begin":105,"end":113},"obj":"Chemical"},{"id":"T183","span":{"begin":239,"end":246},"obj":"Chemical"},{"id":"T184","span":{"begin":284,"end":291},"obj":"Chemical"}],"attributes":[{"id":"A182","pred":"chebi_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"},{"id":"A183","pred":"chebi_id","subj":"T183","obj":"http://purl.obolibrary.org/obo/CHEBI_16541"},{"id":"A184","pred":"chebi_id","subj":"T184","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose.\n\nSARS-CoV Subunit Vaccines Based on Full-Length S Protein\nSubunit vaccines based on SARS-CoV S protein, including full-length or tri"}

{"project":"LitCovid-sentences","denotations":[{"id":"T191","span":{"begin":190,"end":246},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose.\n\nSARS-CoV Subunit Vaccines Based on Full-Length S Protein\nSubunit vaccines based on SARS-CoV S protein, including full-length or tri"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T511","span":{"begin":190,"end":198},"obj":"SP_10"},{"id":"T512","span":{"begin":237,"end":246},"obj":"PG_1"},{"id":"T513","span":{"begin":273,"end":281},"obj":"SP_10"},{"id":"T514","span":{"begin":282,"end":291},"obj":"PG_1"},{"id":"T37785","span":{"begin":190,"end":198},"obj":"SP_10"},{"id":"T18078","span":{"begin":237,"end":246},"obj":"PG_1"},{"id":"T44997","span":{"begin":273,"end":281},"obj":"SP_10"},{"id":"T88305","span":{"begin":282,"end":291},"obj":"PG_1"}],"text":"NTD, N-terminal domain; NZW rabbits, New Zealand White rabbits; RBD, receptor-binding domain; SAS, Sigma adjuvant system; S.C., subcutaneous; TCID50, median tissue culture infectious dose.\n\nSARS-CoV Subunit Vaccines Based on Full-Length S Protein\nSubunit vaccines based on SARS-CoV S protein, including full-length or tri"}